Targeting airway smooth muscle in airways diseases: An old concept with new twists

Expert Review of Respiratory Medicine

Volumn 5, Issue 6, 2011, Pages 767-777

  Koziol White, Cynthia J ^a   Damera, Gautam ^a   Panettieri, Reynold A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antibody therapy; Asthma; Bronchial thermoplasty; Exacerbation; Remodeling

Indexed keywords

ACLIDINIUM BROMIDE; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA INTERFERON; CELL ADHESION MOLECULE; CILOMILAST; CYTOKINE; DEXAMETHASONE; ETANERCEPT; FLUTICASONE; FORMOTEROL; GLUCOCORTICOID; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; MONTELUKAST; PHOSPHODIESTERASE; PITRAKINRA; PLACEBO; PROSTAGLANDIN; ROFLUMILAST; ROLIPRAM; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; THYMIC STROMAL LYMPHOPOIETIN; TIOTROPIUM BROMIDE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

AIRWAY OBSTRUCTION; ASTHMA; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); DISEASE EXACERBATION; HUMAN; HYPERPLASIA; MUSCLE HYPERTROPHY; NONHUMAN; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RHINOVIRUS; SMOOTH MUSCLE;

EID: 81255198735     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.11.77     Document Type: Review

References (88)

1. Dekkers BG, Maarsingh H, Meurs H, Gosens R. Airway structural components drive airway smooth muscle remodeling in asthma. Proc. Am. Thorac. Soc. 6(8), 683-692 (2009).
2. Lazaar AL, Panettieri RA Jr. Airway smooth muscle: a modulator of airway remodeling in asthma. J. Allergy Clin. Immunol. 116(3), 488-495 (2005). (Pubitemid 41267115)
3. Damera G, Panettieri RA Jr. Does airway smooth muscle express an inflammatory phenotype in asthma?. Br. J. Pharmacol. 163(1), 68-80 (2011).
4. Sandstrom T. Effects of pharmacological and non-pharmacological interventions. Clin. Respir. J. 4(Suppl. 1), 41-48 (2010).
5. Thomson NC, Rubin AS, Niven RM et al. Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial. BMC Pulm. Med. 11, 8 (2011).
6. Pavord ID, Cox G, Thomson NC et al. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am. J. Respir. Crit. Care Med. 176(12), 1185-1191 (2007). (Pubitemid 350256471)
7. An SS, Bai TR, Bates JH et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur. Respir. J. 29(5), 834-860 (2007). (Pubitemid 46722226)
8. Damera G, Jiang M, Zhao H et al. Aclidinium bromide abrogates allergeninduced hyperresponsiveness and reduces eosinophilia in murine model of airway inflammation. Eur. J. Pharmacol. 649(1-3), 349-353 (2010).
9. van Noord JA, Aumann JL, Janssens E et al. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest 129(3), 509-517 (2006).
10. Tashkin DP, Littner M, Andrews CP, Tomlinson L, Rinehart M, Denis-Mize K. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. Respir. Med. 102(4), 479-487 (2008).
11. Ammit AJ, Burgess JK, Hirst SJ et al. The effect of asthma therapeutics on signalling and transcriptional regulation of airway smooth muscle function. Pulm. Pharmacol. Ther. 22(5), 446-454 (2009).
12. Trian T, Burgess JK, Niimi K et al. b2-agonist induced cAMP is decreased in asthmatic airway smooth muscle due to increased PDE4D. PLoS One 6(5), e20000 (2011).
13. Adcock IM, Chung KF, Caramori G, Ito K. Kinase inhibitors and airway inflammation. Eur. J. Pharmacol. 533(1-3), 118-132 (2006). (Pubitemid 43340009)
14. Chong J, Poole P, Leung B, Black PN. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 5, CD002309 (2011).
15. Hackett TL, Holloway R, Holgate ST, Warner JA. Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study. Respir. Res. 9, 47 (2008).
16. Thomas PS, Heywood G. Effects of inhaled tumour necrosis factor a in subjects with mild asthma. Thorax 57(9), 774-778 (2002). (Pubitemid 34984975)
17. Jain D, Keslacy S, Tliba O et al. Essential role of IFNb and CD38 in TNFa-induced airway smooth muscle hyper-responsiveness. Immunobiology 213(6), 499-509 (2008).
18. Jude JA, Solway J, Panettieri RA Jr, Walseth TF, Kannan MS. Differential induction of CD38 expression by TNF-{a} in asthmatic airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 299(6), L879-L890 (2010).
19. Prefontaine D, Lajoie-Kadoch S, Foley S et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 183(8), 5094-5103 (2009).
20. Damera G, Zhao H, Wang M et al. Ozone modulates IL-6 secretion in human airway epithelial and smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 296(4), L674-L683 (2009).
21. Redhu NS, Saleh A, Halayko AJ, Ali AS, Gounni AS. Essential role of NF-{κ}B and AP-1 transcription factors in TNF-{α}- induced TSLP expression in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 300(3), L479-L485 (2011).
22. Shan L, Redhu NS, Saleh A, Halayko AJ, Chakir J, Gounni AS. Thymic stromal lymphopoietin receptor-mediated IL-6 and CC/CXC chemokines expression in human airway smooth muscle cells: role of MAPKs (ERK1/2, p38, and JNK) and STAT3 pathways. J. Immunol. 184(12), 7134-7143 (2010).
23. Hughes JM, Arthur CA, Baracho S et al. Human eosinophil-airway smooth muscle cell interactions. Mediators Inflamm. 9(2), 93-99 (2000). (Pubitemid 30482433)
24. Lee CW, Lin CC, Luo SF et al. Tumor necrosis factor-a enhances neutrophil adhesiveness: induction of vascular cell adhesion molecule-1 via activation of Akt and CaM kinase II and modifications of histone acetyltransferase and histone deacetylase 4 in human tracheal smooth muscle cells. Mol. Pharmacol. 73(5), 1454-1464 (2008).
25. Gruenberg D, Busse W. Biologic therapies for asthma. Curr. Opin. Pulm. Med. 16(1), 19-24 (2010).
26. Erin EM, Leaker BR, Nicholson GC et al. The effects of a monoclonal antibody directed against tumor necrosis factor-a in asthma. Am. J. Respir. Crit. Care Med. 174(7), 753-762 (2006). (Pubitemid 44511656)
27. Howarth PH, Babu KS, Arshad HS et al. Tumour necrosis factor (TNFa) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 60(12), 1012-1018 (2005). (Pubitemid 41705469)
28. Berry MA, Hargadon B, Shelley M et al. Evidence of a role of tumor necrosis factor α in refractory asthma. N. Engl. J. Med. 354(7), 697-708 (2006). (Pubitemid 43247140)
29. Morjaria JB, Chauhan AJ, Babu KS, Polosa R, Davies DE, Holgate ST. The role of a soluble TNF-α receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial. Thorax 63(7), 584-591 (2008). (Pubitemid 351969250)
30. Clarke D, Damera G, Sukkar MB, Tliba O. Transcriptional regulation of cytokine function in airway smooth muscle cells. Pulm. Pharmacol. Ther. 22(5), 436-445 (2009).
31. Tliba O, Amrani Y, Panettieri RA Jr. Is airway smooth muscle the missing link' modulating airway inflammation in asthma?. Chest 133(1), 236-242 (2008).
32. Cardell LO, Uddman R, Zhang Y, Adner M. Interleukin-1b up-regulates tumor necrosis factor receptors in the mouse airways. Pulm. Pharmacol. Ther. 21(4), 675-681 (2008). (Pubitemid 351982016)
33. Liang KC, Lee CW, Lin WN et al. Interleukin-1b induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kB signaling pathways in human tracheal smooth muscle cells. J. Cell. Physiol. 211(3), 759-770 (2007).
34. Chan V, Burgess JK, Ratoff JC et al. Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 174(4), 379-385 (2006). (Pubitemid 44223117)
35. Cooper PR, Lamb R, Day ND et al. TLR3 activation stimulates cytokine secretion without altering agonist-induced human small airway contraction or relaxation. Am. J. Physiol. Lung Cell. Mol. Physiol. 297(3), L530-L537 (2009).
36. Cooper PR, Mesaros AC, Zhang J et al. 20-HETE mediates ozone-induced, neutrophil-independent airway hyperresponsiveness in mice. PLoS One 5(4), e10235 (2010).
37. Ohta Y, Hayashi M, Kanemaru T, Abe K, Ito Y, Oike M. Dual modulation of airway smooth muscle contraction by Th2 cytokines via matrix metalloproteinase-1 production. J. Immunol. 180(6), 4191-4199 (2008).
38. Peng Q, Matsuda T, Hirst SJ. Signaling pathways regulating interleukin-13- stimulated chemokine release from airway smooth muscle. Am. J. Respir. Crit. Care Med. 169(5), 596-603 (2004). (Pubitemid 38270895)
39. Nath P, Leung SY, Williams AS et al. Complete inhibition of allergic airway inflammation and remodelling in quadruple IL-4/5/9/13-/- mice. Clin. Exp. Allergy 37(10), 1427-1435 (2007). (Pubitemid 47460223)
40. Amrani Y, Syed F, Huang C et al. Expression and activation of the oxytocin receptor in airway smooth muscle cells: regulation by TNFa and IL-13. Respir. Res. 11, 104 (2010).
41. Wenzel S, Wilbraham D, Fuller R, Getz EB, Longphre M. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two Phase 2a studies. Lancet 370(9596), 1422-1431 (2007). (Pubitemid 47576168)
42. Kunikata T, Yamane H, Segi E et al. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat. Immunol. 6(5), 524-531 (2005). (Pubitemid 41716766)
43. Boyce JA. Eicosanoids in asthma, allergic inflammation, and host defense. Curr. Mol. Med. 8(5), 335-349 (2008).
44. Hallstrand TS, Henderson WR Jr. An update on the role of leukotrienes in asthma. Curr. Opin. Allergy Clin. Immunol. 10(1), 60-66 (2010).
45. Han J, Jia Y, Takeda K et al. Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 182(4), 455-463 (2010).
46. Bjermer L, Bisgaard H, Bousquet J et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ 327(7420), 891 (2003).
47. Fogel RB, Rosario N, Aristizabal G et al. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children. Ann. Allergy Asthma Immunol. 104(6), 511-517 (2010).
48. Clarke DL, Dakshinamurti S, Larsson AK, Ward JE, Yamasaki A. Lipid metabolites as regulators of airway smooth muscle function. Pulm. Pharmacol. Ther. 22(5), 426-435 (2009).
49. Gounni AS, Wellemans V, Yang J et al. Human airway smooth muscle cells express the high affinity receptor for IgE (Fc e RI): a critical role of Fc e RI in human airway smooth muscle cell function. J. Immunol. 175(4), 2613-2621 (2005). (Pubitemid 41113875)
50. Redhu NS, Saleh A, Shan L et al. Proinflammatory and Th2 cytokines regulate the high affinity IgE receptor (FceRI) and IgE-dependant activation of human airway smooth muscle cells. PLoS One 4(7), e6153 (2009).
51. Djukanovic R, Wilson SJ, Kraft M et al. Effects of treatment with antiimmunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am. J. Respir. Crit. Care Med. 170(6), 583-593 (2004).
52. Johnson PR, Burgess JK, Underwood PA et al. Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism. J. Allergy Clin. Immunol. 113, 690-696 (2004). (Pubitemid 38530425)
53. Clarke DL, Clifford RL, Jindarat S et al. TNFa and IFNg synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-kB, and the transcriptional coactivator CREB-binding protein. J. Biol. Chem. 285(38), 29101-29110 (2010).
54. Christodoulopoulos P, Leung DY, Elliott MW et al. Increased number of glucocorticoid receptor-b-expressing cells in the airways in fatal asthma. J. Allergy Clin. Immunol. 106(3), 479-484 (2000). (Pubitemid 32037700)
55. Tliba O, Damera G, Banerjee A et al. Cytokines induce an early steroid resistance in airway smooth muscle cells: novel role of interferon regulatory factor-1. Am. J. Respir. Cell Mol. Biol. 38(4), 463-472 (2008). (Pubitemid 351758693)
56. Bhandare R, Damera G, Banerjee A et al. Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells. Am. J. Respir. Cell Mol. Biol. 42(1), 9-15 (2010).
57. Nakao F, Ihara K, Kusuhara K et al. Association of IFN-g and IFN regulatory factor 1 polymorphisms with childhood atopic asthma. J. Allergy Clin. Immunol. 107(3), 499-504 (2001). (Pubitemid 32210031)
58. Yamada K, Elliott WM, Hayashi S et al. Latent adenoviral infection modifies the steroid response in allergic lung inflammation. J. Allergy Clin. Immunol. 106(5), 844-851 (2000).
59. Banerjee A, Damera G, Bhandare R et al. Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells. Br. J. Pharmacol. 155(1), 84-92 (2008).
60. Bosse Y, Maghni K, Hudson TJ. 1a,25-dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes. Physiol. Genomics 29(2), 161-168 (2007). (Pubitemid 46701997)
61. Song Y, Qi H, Wu C. Effect of 1,25-(OH)2D3 (a vitamin D analogue) on passively sensitized human airway smooth muscle cells. Respirology 12(4), 486-494 (2007). (Pubitemid 46961826)
62. Xystrakis E, Kusumakar S, Boswell S et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J. Clin. Invest. 116(1), 146-155 (2006). (Pubitemid 43121799)
63. Chaudhuri N, Whyte MK, Sabroe I. Reducing the toll of inflammatory lung disease. Chest 131(5), 1550-1556 (2007). (Pubitemid 46762365)
64. Sukkar MB, Xie S, Khorasani NM et al. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J. Allergy Clin. Immunol. 118(3), 641-648 (2006). (Pubitemid 44301394)
65. Lin WN, Luo SF, Lee CW, Wang CC, Wang JS, Yang CM. Involvement of MAPKs and NF-kB in LPS-induced VCAM-1 expression in human tracheal smooth muscle cells. Cell. Signal. 19(6), 1258-1267 (2007).
66. Chiou YL, Lin CY. Der p2 activates airway smooth muscle cells in a TLR2/MyD88-dependent manner to induce an inflammatory response. J. Cell. Physiol. 220(2), 311-318 (2009).
67. Bachar O, Adner M, Uddman R, Cardell LO. Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-κ B signaling pathways. Eur. J. Immunol. 34(4), 1196-1207 (2004). (Pubitemid 39255999)
68. Morris GE, Whyte MK, Martin GF, Jose PJ, Dower SK, Sabroe I. Agonists of Toll-like receptors 2 and 4 activate airway smooth muscle via mononuclear leukocytes. Am. J. Respir. Crit. Care Med. 171(8), 814-822 (2005). (Pubitemid 40562711)
69. Oliver BG, Johnston SL, Baraket M et al. Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection. Respir. Res. 7(1), 71 (2006).
70. Gern JE. The ABCs of rhinoviruses, wheezing, and asthma. J. Virol. 84(15), 7418-7426 (2010).
71. Mackay IM. Human rhinoviruses: the cold wars resume. J. Clin. Virol. 42(4), 297-320 (2008).
72. Nagarkar DR, Wang Q, Shim J et al. CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection. J. Immunol. 183(10), 6698-6707 (2009).
73. Empey KM, Peebles RS Jr, Kolls JK. Pharmacologic advances in the treatment and prevention of respiratory syncytial virus. Clin. Infect. Dis. 50(9), 1258-1267 (2010).
74. Corne JM, Marshall C, Smith S et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359(9309), 831-834 (2002). (Pubitemid 34233753)
75. Kling S, Donninger H, Williams Z et al. Persistence of rhinovirus RNA after asthma exacerbation in children. Clin. Exp. Allergy 35(5), 672-678 (2005). (Pubitemid 40769294)
76. Grunstein MM, Hakonarson H, Maskeri N, Chuang S. Autocrine cytokine signaling mediates effects of rhinovirus on airway responsiveness. Am. J. Physiol. Lung Cell Mol. Physiol. 278(6), L1146-L1153 (2000). (Pubitemid 30439237)
77. Kuo C, Lim S, King NJ et al. Rhinovirus infection induces extracellular matrix protein deposition in asthmatic and nonasthmatic airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 300(6), L951-L957 (2011).
78. Billington CK, Pascual RM, Hawkins ML, Penn RB, Hall IP. Interleukin-1b and rhinovirus sensitize adenylyl cyclase in human airway smooth-muscle cells. Am. J. Respir. Cell Mol. Biol. 24(5), 633-639 (2001). (Pubitemid 32442773)
79. Trian T, Moir LM, Ge Q et al. Rhinovirusinduced exacerbations of asthma: how is the {b}2-adrenoceptor implicated?. Am. J. Respir. Cell Mol. Biol. 43(2), 227-233 (2010).
80. Cooper PR, Panettieri RA Jr. Steroids completely reverse albuterol-induced b(2)-adrenergic receptor tolerance in human small airways. J. Allergy Clin. Immunol. 122(4), 734-740 (2008).
81. Moore PE, Cunningham G, Calder MM et al. Respiratory syncytial virus infection reduces b2-adrenergic responses in human airway smooth muscle. Am. J. Respir. Cell Mol. Biol. 35(5), 559-564 (2006). (Pubitemid 44706428)
82. al-Nakib W, Higgins PG, Barrow GI et al. Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrob. Agents Chemother. 33(4), 522-525 (1989). (Pubitemid 19094285)
83. Turner RB, Dutko FJ, Goldstein NH, Lockwood G, Hayden FG. Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection. Antimicrob. Agents Chemother. 37(2), 297-300 (1993). (Pubitemid 23046572)
84. Hayden FG, Hipskind GJ, Woerner DH et al. Intranasal pirodavir (R77,975) treatment of rhinovirus colds. Antimicrob. Agents Chemother. 39(2), 290-294 (1995).
85. Edwards MR, Kebadze T, Johnson MW, Johnston SL. New treatment regimes for virus-induced exacerbations of asthma. Pulm. Pharmacol. Ther. 19(5), 320-334 (2006). (Pubitemid 44051958)
86. Koziol-White CJ, Panettieri RA Jr. Airway smooth muscle and immunomodulation in acute exacerbations of airway disease. Immunol. Rev. 242, 178-185 (2011).
87. Cox G, Thomson NC, Rubin AS et al. Asthma control during the year after bronchial thermoplasty. N. Engl. J. Med. 356(13), 1327-1337 (2007). (Pubitemid 46513298)
88. Castro M, Rubin AS, Laviolette M et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, doubleblind, sham-controlled clinical trial. Am. J. Respir. Crit. Care Med. 181(2), 116-124 (2010).